{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:29Z","timestamp":1791821129155,"version":"4.3.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":822,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Systemic levels of interferon-gamma-inducible protein-10 (IP-10) are predictive of treatment-induced clearance in chronic hepatitis C virus (HCV). In the present study, factors associated with plasma IP-10 levels at the time of acute HCV detection and the association between IP-10 levels and spontaneous clearance were assessed in three cohorts of acute HCV infection. Among 299 individuals, 245 (181 male, 47 human immunodeficiency virus-positive [HIV+]) were HCV RNA+ at acute HCV detection. In adjusted analysis, factors independently associated with IP-10 levels \u2265150 pg\/mL (median level) included HCV RNA levels &gt;6 log IU\/mL, HIV coinfection and non-Aboriginal ethnicity. Among 245 HCV RNA+ at acute HCV detection, 214 were untreated (n = 137) or had persistent infection (infection duration \u226526 weeks) at treatment initiation (n = 77). Spontaneous clearance occurred in 14% (29 of 214). Individuals without spontaneous clearance had significantly higher mean plasma IP-10 levels at the time of acute HCV detection than those with clearance (248 \u00b1 32 versus 142 \u00b1 22 pg\/mL,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.008). The proportion of individuals with spontaneous clearance was 0% (0 of 22,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.048) and 16% (27 of 165) and in those with and without plasma IP-10 levels \u2265380 pg\/mL. In adjusted analyses, favorable IL28B genotype was associated with spontaneous clearance, while higher HCV RNA level was independently associated with lower odds of spontaneous clearance.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>: High IP-10 levels at acute HCV detection were associated with failure to spontaneously clear HCV. Patients with acute HCV and high baseline IP-10 levels, particularly &gt;380 pg\/mL, should be considered for early therapeutic intervention, and those with low levels should defer therapy for potential spontaneous clearance.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26263","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T16:23:11Z","timestamp":1358353391000},"page":"2124-2134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":57,"title":["Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection"],"prefix":"10.1097","volume":"57","author":[{"given":"Jason","family":"Grebely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Sherker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineke","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzy","family":"Teutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Cherepanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa H.","family":"Shoukry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20241201","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"R2-8-20241201","doi-asserted-by":"crossref","first-page":"14741482","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"R3-8-20241201","doi-asserted-by":"crossref","first-page":"103109","DOI":"10.1016\/j.antiviral.2009.02.203","article-title":"New insights into the immunopathogenesis of chronic hepatitis C.","volume":"82","author":"Diepolder","year":"2009","journal-title":"Antiviral Res"},{"key":"R5-8-20241201","doi-asserted-by":"crossref","first-page":"12161224","DOI":"10.1002\/hep.23850","article-title":"Potential role for Interleukin28B genotype in treatment decisionmaking in recent hepatitis C virus infection.","volume":"52","author":"Grebely","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R8-8-20241201","first-page":"70347039","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C.","volume":"105","author":"SarasinFilipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-8-20241201","doi-asserted-by":"crossref","first-page":"15481563","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment response.","volume":"46","author":"Feld","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R10-8-20241201","doi-asserted-by":"crossref","first-page":"352359","DOI":"10.1002\/hep.21267","article-title":"Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.","volume":"44","author":"He","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R11-8-20241201","doi-asserted-by":"crossref","first-page":"184191","DOI":"10.1016\/j.jhep.2008.04.011","article-title":"Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferonstimulated genes with the response to interferon therapy for chronic hepatitis C.","volume":"49","author":"Su","year":"2008","journal-title":"J Hepatol"},{"key":"R12-8-20241201","doi-asserted-by":"crossref","first-page":"675687","DOI":"10.1111\/j.1365-2893.2006.00838.x","article-title":"The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.","volume":"14","author":"Zeremski","year":"2007","journal-title":"J Viral Hepat"},{"key":"R13-8-20241201","doi-asserted-by":"crossref","first-page":"978988","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"R14-8-20241201","doi-asserted-by":"crossref","first-page":"15231530","DOI":"10.1002\/hep.23509","article-title":"Systemic and intrahepatic interferongammainducible protein 10 kDa predicts the firstphase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C.","volume":"51","author":"Askarieh","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R15-8-20241201","doi-asserted-by":"crossref","first-page":"16171625","DOI":"10.1002\/hep.21407","article-title":"IP10 predicts viral response and therapeutic outcome in difficulttotreat patients with HCV genotype 1 infection.","volume":"44","author":"Lagging","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R16-8-20241201","doi-asserted-by":"crossref","first-page":"895903","DOI":"10.1086\/507307","article-title":"Interferon (IFN)gammainducible protein10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFNalpha 2a and ribavirin for chronic hepatitis C virus infection.","volume":"194","author":"Romero","year":"2006","journal-title":"J Infect Dis"},{"key":"R17-8-20241201","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/hep.24056","article-title":"Quantitation of pretreatment serum interferongammainducible protein10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.","volume":"53","author":"Darling","year":"2011","journal-title":"HEPATOLOGY"},{"key":"R18-8-20241201","doi-asserted-by":"crossref","first-page":"e17232","DOI":"10.1371\/journal.pone.0017232","article-title":"Response prediction in chronic hepatitis C by assessment of IP10 and IL28Brelated single nucleotide polymorphisms.","volume":"6","author":"Lagging","year":"2011","journal-title":"PloS One"},{"key":"R19-8-20241201","doi-asserted-by":"crossref","first-page":"308317","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.","volume":"121","author":"Casrouge","year":"2011","journal-title":"J Clin Invest"},{"key":"R20-8-20241201","doi-asserted-by":"crossref","first-page":"896901","DOI":"10.3109\/00365548.2010.498019","article-title":"IP10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients coinfected with chronic hepatitis C virus infection and HIV.","volume":"42","author":"Falconer","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"R21-8-20241201","doi-asserted-by":"crossref","first-page":"262268","DOI":"10.1097\/QAI.0b013e3180559219","article-title":"Interferon gammainducible protein 10: a predictive marker of successful treatment response in hepatitis C virusHIVcoinfected patients.","volume":"45","author":"Zeremski","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-8-20241201","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/1471-2458-10-633","article-title":"Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort.","volume":"10","author":"Teutsch","year":"2010","journal-title":"BMC Public Health"},{"key":"R23-8-20241201","doi-asserted-by":"crossref","first-page":"13181327","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among streetdrug users.","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"key":"R24-8-20241201","doi-asserted-by":"crossref","first-page":"832836","DOI":"10.1093\/infdis\/jir424","article-title":"CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily AfricanAmerican injection drug users with chronic hepatitis C.","volume":"204","author":"Zeremski","year":"2011","journal-title":"J Infect Dis"},{"key":"R26-8-20241201","doi-asserted-by":"crossref","first-page":"14401450","DOI":"10.1002\/hep.22500","article-title":"Intrahepatic levels of CXCR3associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.","volume":"48","author":"Zeremski","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R27-8-20241201","doi-asserted-by":"crossref","first-page":"10531057","DOI":"10.1086\/520935","article-title":"Elevated serum levels of interferon gamma inducible protein10 in patients coinfected with hepatitis C virus and HIV.","volume":"196","author":"Roe","year":"2007","journal-title":"J Infect Dis"},{"key":"R28-8-20241201","doi-asserted-by":"crossref","first-page":"545553","DOI":"10.1016\/j.jhep.2010.12.033","article-title":"Induction of CXCR3 and CCR5associated chemokines during acute hepatitis C virus infection.","volume":"55","author":"Zeremski","year":"2011","journal-title":"J Hepatol"},{"key":"R29-8-20241201","doi-asserted-by":"crossref","first-page":"447451","DOI":"10.1155\/2007\/796325","article-title":"Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.","volume":"21","author":"Grebely","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"R30-8-20241201","doi-asserted-by":"crossref","first-page":"10511060","DOI":"10.1086\/605561","article-title":"Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.","volume":"49","author":"McGovern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R31-8-20241201","doi-asserted-by":"crossref","first-page":"16841691","DOI":"10.1002\/hep.25575","article-title":"Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.","volume":"55","author":"Liu","year":"2012","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26263","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201306000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:11:48Z","timestamp":1733062308000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201306000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26263","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}